SCHOTT PHARMA : UBS reiterates its Neutral rating : comparem

SCHOTT PHARMA : UBS reiterates its Neutral rating

Initially Neutral on the company, UBS's analyst Olivier Calvet maintained his recommendation. The target price is decreased from EUR 40 to EUR 33.

Related Keywords

Olivier Calvet , , Initially Neutral ,

© 2024 Vimarsana
SCHOTT PHARMA : UBS Reiterates Its Neutral Rating : Comparemela.com

SCHOTT PHARMA : UBS reiterates its Neutral rating

Card image cap

Initially Neutral on the company, UBS's analyst Olivier Calvet maintained his recommendation. The target price is decreased from EUR 40 to EUR 33.

Related Keywords

Olivier Calvet , , Initially Neutral ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.